SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Know Labs, Inc. (KNW) , forward earnings yield 555.56%. PEG 0.03 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 0.2
- PEG Ratio 0.03 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Overall SharesGrow Score: 39/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — KNW
Valuation Multiples
P/E (TTM)0.0
Forward P/E0.2
PEG Ratio0.03
Forward PEG0.03
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.39
Forward EPS (Est.)$12.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield555.56%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-1.22 |
$6.02M |
$-1.75M |
-29% |
| 2017 |
$-1.01 |
$4.87M |
$-3.9M |
-80% |
| 2018 |
$-0.38 |
$4.3M |
$-3.26M |
-75.7% |
| 2019 |
$-0.58 |
$1.81M |
$-7.61M |
-421.7% |
| 2020 |
$-0.91 |
$121.94K |
$-13.56M |
-11122.8% |
| 2021 |
$-1.37 |
$0.00 |
$-40.27M |
- |
| 2022 |
$-20.00 |
$4.36M |
$-20.07M |
-460.3% |
| 2023 |
$-0.41 |
$0.00 |
$-15.29M |
- |
| 2024 |
$-0.19 |
$0.00 |
$-16.58M |
- |
| 2025 |
$-0.39 |
$0.00 |
$-24.35B |
- |